• Share
  • Email
  • Embed
  • Like
  • Private Content
U.S. Biosimilars - Red Flags for Patent Attorneys
 

U.S. Biosimilars - Red Flags for Patent Attorneys

on

  • 1,782 views

On March 14, 2013, Knobbe Martens Partner Carol Pitzel Cruz presented at the 24th C5 Forum on Biotech Patenting 2013. The presentation was titled "The Red Flags Every Patent Attorney Needs to Know to ...

On March 14, 2013, Knobbe Martens Partner Carol Pitzel Cruz presented at the 24th C5 Forum on Biotech Patenting 2013. The presentation was titled "The Red Flags Every Patent Attorney Needs to Know to Successfully Navigate the Regulatory Landscape for Biosimilars" and Pitzel Cruz covered the U.S. law.

Her presentation analyzed the key features of the new Food and Drug Administration guidelines for American biosimilar approval under the Biologics Price Competition and Innovation Act.

Statistics

Views

Total Views
1,782
Views on SlideShare
1,581
Embed Views
201

Actions

Likes
1
Downloads
26
Comments
0

6 Embeds 201

http://knobbe.com 86
http://www.knobbe.com 67
http://accessibility_checker.siteimprove.com 45
https://twitter.com 1
http://iprismoc.kmob.com 1
http://www.kmob.com 1

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    U.S. Biosimilars - Red Flags for Patent Attorneys U.S. Biosimilars - Red Flags for Patent Attorneys Presentation Transcript